Pancreatic Cancer Research

ResearcherNational Center for Nanoscience and TechnologyActive in the last 2 years

Chen Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5685-912X; OpenAlex author ID A5121539146. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2025: 2 papers

Papers 2

  1. Development of a CXCR4 antagonistic peptide, P12, to suppress pancreatic cancer progress via enhancing T cell responses and sensitizing cells to gemcitabine. Co-author DOI 10.1039/d5md00488h↗
  2. Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer. Last author DOI 10.1039/d5md00970g↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiangyu Chu · 1 shared paper, 2025 · strength 0.26
  2. Mengting Chen · 1 shared paper, 2025 · strength 0.26
  3. Haiyan Xu · 1 shared paper, 2025 · strength 0.22
  4. Ke Zhu · 1 shared paper, 2025 · strength 0.22
  5. Xin Huang · 1 shared paper, 2025 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.